002793 罗欣药业
已收盘 03-13 15:00:00
资讯
新帖
简况
罗欣药业：截止至2026年3月10日，公司股东总户数为36,780
证券之星 · 03-11 15:48
罗欣药业：截止至2026年3月10日，公司股东总户数为36,780
罗欣药业(002793)2月27日股东户数3.69万户，较上期减少1.95%
证券之星 · 03-02
罗欣药业(002793)2月27日股东户数3.69万户，较上期减少1.95%
【市场】17个国谈药拟进院，独家品种霸屏
米内网 · 02-25
【市场】17个国谈药拟进院，独家品种霸屏
罗欣药业：公司最新一期（2026年2月13日）股东总户数为37,614
证券之星 · 02-24
罗欣药业：公司最新一期（2026年2月13日）股东总户数为37,614
罗欣药业：截止至2026年2月10日，公司股东总户数为38,789
证券之星 · 02-11
罗欣药业：截止至2026年2月10日，公司股东总户数为38,789
罗欣药业：注射用LX22001目前已进入Ⅱ期临床试验阶段
证券之星 · 02-02
罗欣药业：注射用LX22001目前已进入Ⅱ期临床试验阶段
股市必读：罗欣药业（002793）预计2025年全年归属净利润亏损2.5亿元至3.4亿元
证券之星 · 02-02
股市必读：罗欣药业（002793）预计2025年全年归属净利润亏损2.5亿元至3.4亿元
罗欣药业2025年业绩预告释放了哪些信号？
中金财经 · 01-30
罗欣药业2025年业绩预告释放了哪些信号？
股市必读：罗欣药业（002793）1月28日董秘有最新回复
证券之星 · 01-29
股市必读：罗欣药业（002793）1月28日董秘有最新回复
罗欣药业：截止至2026年1月20日股东总户数为38,213
证券之星 · 01-21
罗欣药业：截止至2026年1月20日股东总户数为38,213
罗欣药业低价“甩卖”子公司引争议，“止血”背后藏匿多重风险
新浪证券 · 01-16
罗欣药业低价“甩卖”子公司引争议，“止血”背后藏匿多重风险
罗欣药业（002793）披露召开2026年第一次临时股东会通知，1月13日股价上涨1.0%
证券之星 · 01-13
罗欣药业（002793）披露召开2026年第一次临时股东会通知，1月13日股价上涨1.0%
股市必读：罗欣药业(002793)股东户数3.83万户，较上期减少0.94%
中金财经 · 01-13
股市必读：罗欣药业(002793)股东户数3.83万户，较上期减少0.94%
罗欣药业：公司最新一期股东总户数为38,283
证券之星 · 01-12
罗欣药业：公司最新一期股东总户数为38,283
罗欣药业（002793）披露为控股子公司提供担保的进展公告，1月8日股价上涨1.85%
证券之星 · 01-08
罗欣药业（002793）披露为控股子公司提供担保的进展公告，1月8日股价上涨1.85%
罗欣药业（002793）披露转让控股子公司股权进展，1月7日股价下跌1.82%
证券之星 · 01-07
罗欣药业（002793）披露转让控股子公司股权进展，1月7日股价下跌1.82%
罗欣药业：截至2025年12月31日股东户数为38,648
证券之星 · 01-05
罗欣药业：截至2025年12月31日股东户数为38,648
每周股票复盘：罗欣药业（002793）泰欣赞进院近2500家销售增140%
证券之星 · 01-03
每周股票复盘：罗欣药业（002793）泰欣赞进院近2500家销售增140%
罗欣药业（002793）披露转让控股子公司股权暨被动形成财务资助公告，12月30日股价下跌0.42%
证券之星 · 2025-12-30
罗欣药业（002793）披露转让控股子公司股权暨被动形成财务资助公告，12月30日股价下跌0.42%
罗欣药业：交银施罗德基金、广发基金等多家机构于12月28日调研我司
证券之星 · 2025-12-30
罗欣药业：交银施罗德基金、广发基金等多家机构于12月28日调研我司
公司概况
公司名称：
罗欣药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2016-04-15
主营业务：
罗欣药业集团股份有限公司的主营业务是医药产品的研发、生产和销售。公司的主要产品是替戈拉生片、注射用美罗培南、奥美拉唑肠溶胶囊、注射用头孢呋辛钠、注射用头孢美唑钠、注射用克林霉素磷酸酯、注射用谷胱甘肽、注射用盐酸氨溴索、注射用雷贝拉唑钠。
发行价格：
11.97
{"stockData":{"symbol":"002793","market":"SZ","secType":"STK","nameCN":"罗欣药业","latestPrice":4.81,"timestamp":1773385383000,"preClose":4.85,"halted":0,"volume":9455068,"delay":0,"changeRate":-0.0082,"floatShares":1086000000,"shares":1088000000,"eps":-0.6227,"marketStatus":"已收盘","change":-0.04,"latestTime":"03-13 15:00:00","open":4.85,"high":4.9,"low":4.81,"amount":45888600,"amplitude":0.0186,"askPrice":4.82,"askSize":130,"bidPrice":4.81,"bidSize":1141,"shortable":0,"etf":0,"ttmEps":-0.6227,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773624600000},"marketStatusCode":5,"adr":0,"adjPreClose":4.85,"symbolType":"stock","openAndCloseTimeList":[[1773365400000,1773372600000],[1773378000000,1773385200000]],"highLimit":5.34,"lowLimit":4.37,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1087588486,"isCdr":false,"pbRate":3.63,"roa":"--","roe":"1.62%","epsLYR":-0.91,"committee":0.096203,"marketValue":5231000000,"turnoverRate":0.0087,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-03-16。","floatMarketCap":5223000000},"requestUrl":"/m/hq/s/002793/wiki","defaultTab":"wiki","newsList":[{"id":"2618121911","title":"罗欣药业：截止至2026年3月10日，公司股东总户数为36,780","url":"https://stock-news.laohu8.com/highlight/detail?id=2618121911","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618121911?lang=zh_cn&edition=full","pubTime":"2026-03-11 15:48","pubTimestamp":1773215286,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)03月11日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至3月10日的股东人数是多少？谢谢罗欣药业回复：尊敬的投资者，您好！截止至2026年3月10日，公司股东总户数为36,780。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100022278.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","08058","BK0001","002793","BK0132","BK0239"],"gpt_icon":0},{"id":"2616387954","title":"罗欣药业(002793)2月27日股东户数3.69万户，较上期减少1.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616387954","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616387954?lang=zh_cn&edition=full","pubTime":"2026-03-02 17:30","pubTimestamp":1772443853,"startTime":"0","endTime":"0","summary":"证券之星消息，近日罗欣药业披露，截至2026年2月27日公司股东户数为3.69万户，较2月13日减少735.0户，减幅为1.95%。在化学制药行业个股中，罗欣药业股东户数高于行业平均水平，截至2月27日，化学制药行业平均股东户数为3.42万户。从股价来看，2026年2月13日至2026年2月27日，罗欣药业区间涨幅为1.44%，在此期间股东户数减少735.0户，减幅为1.95%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200025586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002793","BK0132","08058","BK0201","BK0001"],"gpt_icon":0},{"id":"2614554709","title":"【市场】17个国谈药拟进院，独家品种霸屏","url":"https://stock-news.laohu8.com/highlight/detail?id=2614554709","media":"米内网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614554709?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:07","pubTimestamp":1772006826,"startTime":"0","endTime":"0","summary":"精彩内容近日，成都市第六人民医院发布招标公示，将组织拟引入药品生产企业遴选工作。17个新药在列，均为国谈药，涵盖化学药及生物药，既有环泊酚注射液等超10亿大品种，亦有芦比前列酮软胶囊、替戈拉生片等2025年前三季度销售额增速达三位数的高增长品种。17个新药均为国谈药，目前均已纳入国家医保乙类目录，主要集中在消化系统及代谢、神经系统、心脑血管系统等治疗领域，可见以慢病药、常见病药为主。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602251615059541ed56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602251615059541ed56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","NVOH","01276","BK4585","002653","BK4588","NVO","NVS","LU1093756325.SGD","NVOX","600276","IE00BKVL7J92.USD","BK4007","LU0154236417.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4532","002793"],"gpt_icon":1},{"id":"2613798736","title":"罗欣药业：公司最新一期（2026年2月13日）股东总户数为37,614","url":"https://stock-news.laohu8.com/highlight/detail?id=2613798736","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613798736?lang=zh_cn&edition=full","pubTime":"2026-02-24 15:51","pubTimestamp":1771919475,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)02月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止到2月20日（2月13日收盘）公司的股东人数是多少？谢谢罗欣药业回复：尊敬的投资者，您好！公司最新一期（2026年2月13日）股东总户数为37,614。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400025897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","002793","BK0001","08058","BK0132"],"gpt_icon":0},{"id":"2610060106","title":"罗欣药业：截止至2026年2月10日，公司股东总户数为38,789","url":"https://stock-news.laohu8.com/highlight/detail?id=2610060106","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610060106?lang=zh_cn&edition=full","pubTime":"2026-02-11 11:34","pubTimestamp":1770780869,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)02月11日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘你好，请问截止至2026年2月10日收盘公司股东人数为多少，谢谢！罗欣药业回复：尊敬的投资者，您好！截止至2026年2月10日，公司股东总户数为38,789。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021100014321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","08058","BK0132","002793","BK0001","BK0239"],"gpt_icon":0},{"id":"2608385601","title":"罗欣药业：注射用LX22001目前已进入Ⅱ期临床试验阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2608385601","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608385601?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:18","pubTimestamp":1770020288,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)02月02日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司有没有最新前沿药物要发布？罗欣药业回复：尊敬的投资者，您好！公司重点研发的注射用LX22001目前已进入Ⅱ期临床试验阶段；普卡那肽片Ⅲ期临床研究报告已完成定稿，正在进行地产化落地；公司其他产品线布局情况请关注公司定期报告。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200021734.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","002793","08058","BK0001","BK0132"],"gpt_icon":0},{"id":"2608897818","title":"股市必读：罗欣药业（002793）预计2025年全年归属净利润亏损2.5亿元至3.4亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608897818","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608897818?lang=zh_cn&edition=full","pubTime":"2026-02-02 03:56","pubTimestamp":1769975771,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，罗欣药业报收于4.84元，下跌0.82%，换手率1.27%，成交量13.83万手，成交额6699.43万元。业绩披露要点罗欣药业发布业绩预告，预计2025年全年归属净利润亏损2.5亿元至3.4亿元。业绩亏损主因包括上药罗欣业绩未达预期导致的公允价值变动损失、部分股权投资出现减值迹象，以及乐康制药等亏损业务在处置前的拖累。此外，公司于2026年1月29日召开职工代表大会，选举马少红为第六届董事会职工代表董事。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200001838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","002793"],"gpt_icon":0},{"id":"2607109049","title":"罗欣药业2025年业绩预告释放了哪些信号？","url":"https://stock-news.laohu8.com/highlight/detail?id=2607109049","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607109049?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:07","pubTimestamp":1769782025,"startTime":"0","endTime":"0","summary":"1月30日，罗欣药业发布2025年业绩预告。报告期内，公司预计2025年度归属于母公司所有者的净利润将出现亏损，区间为万元至万元。与上年同期(万元)相比，亏损额预计大幅减少万元至万元，同比减亏幅度达%至%。 报告同时显示，罗欣药业2025年净利润大幅减亏的原因是其核心创新药产品替戈拉生片快速增长的拉动和产品结构和增长质量持续提升。 今天我们就借机来分析一下，罗欣药业这家老牌公司，当下及未来有哪些看点？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260130/31988133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","002793","BK0001","BK0201","08058","BK0132"],"gpt_icon":0},{"id":"2607744161","title":"股市必读：罗欣药业（002793）1月28日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2607744161","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607744161?lang=zh_cn&edition=full","pubTime":"2026-01-29 02:59","pubTimestamp":1769626748,"startTime":"0","endTime":"0","summary":"截至2026年1月28日收盘，罗欣药业报收于4.91元，下跌2.19%，换手率1.17%，成交量12.7万手，成交额6301.08万元。董秘最新回复投资者： 请问公司定增情况怎么样了？是否引入国资参与定增？目前公司定增工作正常推进中，后续进展请关注公司公告。当日关注点来自交易信息汇总：1月28日主力资金净流出210.99万元，散户资金净流入314.73万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900001652.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","08058","BK0001","002793","BK0201","BK0239"],"gpt_icon":0},{"id":"2605439172","title":"罗欣药业：截止至2026年1月20日股东总户数为38,213","url":"https://stock-news.laohu8.com/highlight/detail?id=2605439172","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605439172?lang=zh_cn&edition=full","pubTime":"2026-01-21 16:57","pubTimestamp":1768985828,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)01月21日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问公司到1月20日的股东人数，谢谢罗欣药业回复：尊敬的投资者，您好！截止至2026年1月20日，公司股东总户数为38,213。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100027385.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","BK0239","002793","08058","BK0132","BK0201"],"gpt_icon":0},{"id":"2603969552","title":"罗欣药业低价“甩卖”子公司引争议，“止血”背后藏匿多重风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2603969552","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603969552?lang=zh_cn&edition=full","pubTime":"2026-01-16 17:09","pubTimestamp":1768554540,"startTime":"0","endTime":"0","summary":"近日，罗欣药业（维权）一则转让控股子公司的公告引发市场关注。公司将以6250万元的价格将旗下乐康制药100%股权转让给成立仅两年、注册资本仅20万元的君康生物。而截至2025年9月30日，乐康制药净资产为7323.83万元，交易价明显低于净资产。 这笔“低价出售”背后，不仅暴露出标的公司持续亏损、资产萎缩的经营困境，也折射出罗欣药业近年来为扭亏频频剥离资产、债务压力渐显的复杂局面。 乐康制药并非罗欣药业近期出售的唯一资产。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-01-16/doc-inhhnzav3923248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0132","08058","BK0001","BK0201","BK0239","002793"],"gpt_icon":0},{"id":"2603381616","title":"罗欣药业（002793）披露召开2026年第一次临时股东会通知，1月13日股价上涨1.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603381616","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603381616?lang=zh_cn&edition=full","pubTime":"2026-01-13 22:38","pubTimestamp":1768315094,"startTime":"0","endTime":"0","summary":"截至2026年1月13日收盘，罗欣药业报收于5.04元，较前一交易日上涨1.0%，最新总市值为54.81亿元。该股当日开盘5.01元，最高5.14元，最低4.99元，成交额达1.23亿元，换手率为2.24%。近日，罗欣药业发布公告称，公司将于2026年1月29日召开2026年第一次临时股东会，会议由董事会召集，现场会议地点位于上海市浦东新区东育路255弄4号前滩世贸中心一期A栋7层会议室。其中部分议案需经出席会议的股东所持表决权的三分之二以上通过，关联股东需回避表决。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300042539.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","08058","BK0201","BK0132","002793","BK0001"],"gpt_icon":0},{"id":"2603522779","title":"股市必读：罗欣药业(002793)股东户数3.83万户，较上期减少0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603522779","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603522779?lang=zh_cn&edition=full","pubTime":"2026-01-13 08:00","pubTimestamp":1768262439,"startTime":"0","endTime":"0","summary":"来自股本股东变化：截至2026年1月9日，罗欣药业股东户数为3.83万户，较前期减少365户，户均持股升至2.84万股。资金流向1月12日主力资金净流出1174.94万元；游资资金净流入310.47万元；散户资金净流入864.47万元。股东户数变动近日罗欣药业披露，截至2026年1月9日公司股东户数为3.83万户，较12月31日减少365.0户，减幅为0.94%。户均持股数量由上期的2.81万股增加至2.84万股，户均持股市值为14.29万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260113/31936006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","002793","BK0001","BK0201","08058","BK0132"],"gpt_icon":0},{"id":"2602591038","title":"罗欣药业：公司最新一期股东总户数为38,283","url":"https://stock-news.laohu8.com/highlight/detail?id=2602591038","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602591038?lang=zh_cn&edition=full","pubTime":"2026-01-12 15:42","pubTimestamp":1768203728,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)01月12日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至1月10日的股东人数是多少？罗欣药业回复：尊敬的投资者，您好！公司最新一期（2026年1月9日）股东总户数为38,283。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200015194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","08058","BK0239","BK0201","BK0001","002793"],"gpt_icon":0},{"id":"2601398561","title":"罗欣药业（002793）披露为控股子公司提供担保的进展公告，1月8日股价上涨1.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601398561","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601398561?lang=zh_cn&edition=full","pubTime":"2026-01-08 22:30","pubTimestamp":1767882638,"startTime":"0","endTime":"0","summary":"截至2026年1月8日收盘，罗欣药业报收于4.95元，较前一交易日上涨1.85%，最新总市值为53.84亿元。公司近日发布公告称，罗欣药业集团股份有限公司近日与中国农业银行股份有限公司临沂罗庄支行签署《最高额保证合同》，为控股子公司山东罗欣药业集团股份有限公司提供最高额5,000万元的连带责任保证担保，用于其开展无追索权保理业务。公司及控股子公司对外担保总余额为115,232.57万元，占最近一期经审计净资产的83.36%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800039132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","002793","BK0239","BK0201","BK0132","BK0001"],"gpt_icon":0},{"id":"2601180182","title":"罗欣药业（002793）披露转让控股子公司股权进展，1月7日股价下跌1.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601180182","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601180182?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:25","pubTimestamp":1767795922,"startTime":"0","endTime":"0","summary":"公司近日发布公告称，罗欣药业集团股份有限公司于2025年12月29日召开董事会，同意下属子公司山东罗欣将其持有的乐康制药100%股权转让给临沂君康，转让对价为6,250万元。股权转让后，乐康制药不再纳入公司合并报表范围。截至公告日，乐康制药尚欠山东罗欣280.05万元本金及利息，该款项将被动形成对外财务资助，约定于2026年10月26日前清偿完毕。乐康制药已完成工商变更登记。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700038963.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","BK0132","BK0201","08058","BK0239","002793"],"gpt_icon":0},{"id":"2601003087","title":"罗欣药业：截至2025年12月31日股东户数为38,648","url":"https://stock-news.laohu8.com/highlight/detail?id=2601003087","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601003087?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:15","pubTimestamp":1767597322,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)01月04日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至12月31日的股东人数是多少？谢谢罗欣药业回复：尊敬的投资者，您好！截止至2025年12月31日，公司股东总户数为38,648。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015091.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","08058","BK0201","BK0132","BK0001","BK0239"],"gpt_icon":0},{"id":"2600098389","title":"每周股票复盘：罗欣药业（002793）泰欣赞进院近2500家销售增140%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600098389","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600098389?lang=zh_cn&edition=full","pubTime":"2026-01-03 04:13","pubTimestamp":1767384789,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，罗欣药业报收于4.8元，较上周的4.87元下跌1.44%。本周，罗欣药业12月29日盘中最高价报4.86元。本周关注点来自机构调研要点：泰欣赞2025年上半年进院数量近2500家，销量同比增140%。来自公司公告汇总：拟转让乐康制药100%股权，交易对价6,250万元。销售费用率下降主要受益于泰欣赞销售收入规模化增长带来的规模效应。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","BK0132","BK0239","002793","08058","BK0201"],"gpt_icon":0},{"id":"2595959937","title":"罗欣药业（002793）披露转让控股子公司股权暨被动形成财务资助公告，12月30日股价下跌0.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595959937","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595959937?lang=zh_cn&edition=full","pubTime":"2025-12-30 17:58","pubTimestamp":1767088686,"startTime":"0","endTime":"0","summary":"截至2025年12月30日收盘，罗欣药业报收于4.78元，较前一交易日下跌0.42%，最新总市值为51.99亿元。近日，罗欣药业集团股份有限公司发布关于转让控股子公司股权暨被动形成财务资助的公告。公告显示，公司下属子公司山东罗欣拟将其持有的山东罗欣乐康制药有限公司100%股权转让给临沂君康生物有限公司，转让对价为6,250万元。因转让前山东罗欣向乐康制药提供借款280.05万元本金及利息，交易完成后将被动形成对外财务资助，约定于2026年10月26日前清偿完毕。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000030892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0132","002793","BK0239","08058","BK0001"],"gpt_icon":0},{"id":"2595175752","title":"罗欣药业：交银施罗德基金、广发基金等多家机构于12月28日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2595175752","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595175752?lang=zh_cn&edition=full","pubTime":"2025-12-30 10:01","pubTimestamp":1767060086,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年12月29日罗欣药业发布公告称交银施罗德基金、广发基金、国海证券、中邮证券于2025年12月28日调研我司。公司分别于2025年 9月 29日、2025年 11月 14日召开董事会、股东会审议,于2025年9月30日在巨潮资讯网披露了本次发行预案,发行决议的有效期为自公司股东会审议通过之日起12个月。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000010878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","BK0001","002793","BK0239","BK0132","BK0201"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1773460994552,"stockEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":-0.0569},{"period":"3month","weight":-0.0283},{"period":"6month","weight":-0.1255},{"period":"1year","weight":0.2397},{"period":"ytd","weight":0.0021}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":-0.0088},{"period":"3month","weight":0.053},{"period":"6month","weight":0.0581},{"period":"1year","weight":0.2193},{"period":"ytd","weight":0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"罗欣药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"36780人(较上一季度减少0.27%)","perCapita":"29525股","listingDate":"2016-04-15","address":"山东省临沂市罗庄区罗七路18号4号楼","registeredCapital":"108758万元","survey":" 罗欣药业集团股份有限公司的主营业务是医药产品的研发、生产和销售。公司的主要产品是替戈拉生片、注射用美罗培南、奥美拉唑肠溶胶囊、注射用头孢呋辛钠、注射用头孢美唑钠、注射用克林霉素磷酸酯、注射用谷胱甘肽、注射用盐酸氨溴索、注射用雷贝拉唑钠。","listedPrice":11.97},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"罗欣药业(002793)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供罗欣药业(002793)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"罗欣药业,002793,罗欣药业股票,罗欣药业股票老虎,罗欣药业股票老虎国际,罗欣药业行情,罗欣药业股票行情,罗欣药业股价,罗欣药业股市,罗欣药业股票价格,罗欣药业股票交易,罗欣药业股票购买,罗欣药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"罗欣药业(002793)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供罗欣药业(002793)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}